Skip to content
Review Open access

From Perinatal Stress to Schizophrenia: The Emerging Role of Glial Pathology

Jul 2026 · Annals of Neurosciences · 0 citations · 98 references
Medicine

TL;DR

Perinatal stressor-associated negative changes in glia can predispose an individual to develop this disorder later in life, and could contribute to the neurobiological mechanism underlying schizophrenia.

Abstract

Background Glia are the non-excitable cells of the brain, which, upon hyperstimulation, give rise to neuropsychiatric disorders. Recent evidence suggests that they are highly reactive cells, which makes them prone to environmental stimuli and early-life stressors. Upon excessive or chronic stimulation through exposure to stressors, these cells become responsible for causing neurological damage, which leads to neuropsychiatric disorders like schizophrenia, a global burden with no definite interventions. Purpose Perinatal stressors such as protein malnourishment, immunological disturbances, toxins, parental separation and abuse play a major role in negatively changing the cytoarchitecture and homeostasis of both neurons and glial cells (astrocytes, microglia and oligodendrocytes), finally degrading both cognitive and behavioural abilities. Effects of excessive glial activation and/or degeneration result in neuroinflammation, memory loss, anxiety, depression and hyperactivity-like symptoms in adult individuals, which contribute to the manifestation of schizophrenic pathology. Conclusion Therefore, it is believed that perinatal stressor-associated negative changes in glia can predispose an individual to develop this disorder later in life. This review summarises current evidence on how diverse early-life stressors influence glial cells, which could contribute to the neurobiological mechanism underlying schizophrenia.

Read PDF

Similar papers

Review 2026

Astroglial dysregulation and gliotransmitter imbalance in schizophrenia.

Insight into the scientific concepts that interrelate the pathophysiology of schizophrenia with astroglia dysregulation at the level of gliotransmitter imbalance could provide innovative hints for developing therapeutic strategies for the treatment of schizophrenia.

Mercy Priyadharshini Babu Deva Irakkam, Mahesh Kandasamy · 0 citations
Aug 2026

Neuroinflammation as a Pharmacological Target in Psychiatric Disorders.

A comprehensive understanding of neuroinflammatory mechanisms may provide new opportunities for developing targeted therapeutic interventions and improving clinical outcomes in psychiatric disorders, including patient stratification and enable precision psychiatry.

P. Karwa, Vaibhav Parekar, Sarthak Buttepatil et al. · 1 citation
Review 2026

Microglial advances in psychiatric disorders.

Emerging therapeutic strategies targeting microglia were discussed, including anti-inflammatory approaches, functional reprogramming, neuromodulation techniques, and microglial replacement or niche engineering, indicating a paradigm shift from indiscriminate microglia inhibition to the precise modulation of specific fu...

J. R. de Jesus, I. S. Ribeiro, Marcos V. S. Pereira et al. · 0 citations
Review Sep 2026

The role of inflammation in neurodevelopment and childhood psychiatric disorders.

PURPOSE OF REVIEW This review examines how prenatal inflammation may contribute to psychiatric and neurodevelopmental disorders, with a focus on maternal immune activation, microglial programming, and epigenetic mechanisms. RECENT FINDINGS Recent studies have found that inflammation during pregnancy is associated wit...

Alexandra U. Zezulin, Jonathan Posner · 0 citations
Review Aug 2026

Microgliopathy in poststroke depression: exploring mechanisms and therapeutic strategies.

This proposed microglial sensitization model provides a conceptual framework for understanding delayed PSD, although direct causal evidence remains insufficient, and aligns more with "microgliopathy" than with depression-only.

Chen Yang, Si-Yuan Wu, Heng-Rui Cao et al. · 0 citations
Review Open access Aug 2026

Neuroinflammation, Oxidative Stress, and the BDNF–TrkB–mTOR Axis in Depression

The role of brain-derived neurotrophic factor (BDNF) in neuronal survival, synaptic plasticity, dendritic development, and hippocampal neurogenesis provides an important framework for understanding the cellular and molecular basis of the disorder.

Besra Yarat · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.